The 23 references in paper E. Makeeva R., A. Shutov M., V. Serov A., O. Troshenkina V., S. Hiteva V., Е. Макеева Р., А. Шутов М., В. Серов А., О. Трошенькина В., С. Хитева В. (2010) “ХРОНИЧЕСКАЯ БОЛЕЗНЬ ПОЧЕК ВЛИЯЕТ НА ПРОГНОЗ И СТОИМОСТЬ СТАЦИОНАРНОГО ЛЕЧЕНИЯ БОЛЬНЫХ С ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ // CHRONIC KIDNEY DISEASE INFLUENCE ON PROGNOSIS AND READMISSION COST IN PATIENTS WITH CHRONIC HEART FAILURE” / spz:neicon:nefr:y:2010:i:2:p:51-55

1
Фомин ИВ, Беленков ЮН, Мареев ВЮ. Распростреннесть ХСН в Европейской части Российской Федерации - данные ЭПОХА-ХСН. Журнал сердечная недоста­ точность 2006; 7(1): 4-7
(check this in PDF content)
2
McMurray JJ, Petrie MC, Murdoch DR, Davie AP Clinical epidemiology of heart failure: public and private health burden. Eur Heart J 1998;19 (Suppl P):P9-16
(check this in PDF content)
3
Jaarsma T, Halfens RJ, Huijer-Abu Saad H. Readmission of older heart failure patients. Prog Cardiovasc Nurs 1996;11(1):15-20
(check this in PDF content)
4
Национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН (третий пересмотр). Журнал сердечная не­ достаточность 2009; 2 (52): 64-106
(check this in PDF content)
5
Hillege H, Girbes A, de Kam P et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000; 102: 203-210
(check this in PDF content)
6
Hamer RA, El Nahas AM. The burden of chronic kidney disease. BMJ 2006; 332:563-564
(check this in PDF content)
7
Barsoum RS. Chronic kidney disease in the developing world. N Engl J Med 2006; 354:997-999
(check this in PDF content)
8
Levey AS, Andreoli SP, DuBose T et al. Chronic kidney disease: common, harmful, and treatable—World Kidney Day 2007. J Am Soc Nephrol 2007; 18:374-378
(check this in PDF content)
9
Meguid El, Nahas A, Bello AK. Chronic kidney disease: the global challenge. Lancet 2005; 365:331-340
(check this in PDF content)
10
Frank C, Thomas H, Mark M et al. Detection of Chronic Kidney Disease in Patients With or at Increased Risk of Cardiovascular Disease. Circulation 2006;114:1083-1087
(check this in PDF content)
11
Go AS, Chertow GM, Fan D. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-1305
(check this in PDF content)
12
Ibsen H, Olsen MH, Wachtell K et al. Reduction in albuminuria translated to reduction in cardiovascular events in hypertensive patients. Hypertension 2005; 45 (2): 198-202
(check this in PDF content)
13
Карпов ЮА, Мареев ВЮ, Чазова ИЕ. Российские программы оценки эффективности лечения фозиноприлом больных с артериальной гипертонией и сердечной недо­ статочностью. Проект ТРИ Ф (ФЛАГ,ФАСОН,ФАГОТ). Сер­ дечная недостаточность 2003; 4 (5): 261-265
(check this in PDF content)
14
Brewster UC, Setaro JF, Perazella MA. The rennin- angiotensin-aldoserone system: Cardiorenal effects and implications for renal and cardiovascular disease states. Am J Med Sci 2003; 326 (1):15-24
(check this in PDF content)
15
Kotanco P Cause and consequences of sympathetic hyperactivity in chronic kidney disease. Blood Purif 2006; 24(1): 95-99
(check this in PDF content)
16
Национальные Рекомендации ВНОК И ОССН по ди­ агностике и лечению ХСН (второй пересмотр). Сердечная недостаточность 2007; 8(1): 4-41
(check this in PDF content)
17
Zakai NA, Katz R, Hirsch C et al. A Prospective Study of Anemia Status, Hemoglobin Concentration, and Mortality in an Elderly Cohort. The Cardiovascular Health Study. Arch Intern Med 2005; 165 (19): 2214-2220
(check this in PDF content)
18
Caramelo C, Justo S, Gil P Anemia in heart failure: pathophysiology, pathogenesis, treatment, and incognitae. Rev ESP Cardiol 2007; 60(80): 848-860
(check this in PDF content)
19
Kannel W. Epidemiology and prevention of cardiac failure: Framingham Study insights. EUR Heart J 1987; 8 (Suppl F): 23-29
(check this in PDF content)
20
Petretta M, Scopacasa F, Fontanella L et al. Prognostic value of reduced kidney function and anemia in patients with chronic heart failure. J Cardiovasc Med (Hagerstown) 2007; 8(11): 909-916
(check this in PDF content)
21
Smith DH, Gullion CM, Nichols G et al. Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population. J Am Soc Nephrol 2004; 15:1300-1306
(check this in PDF content)
22
Gregory DD, Sarnak MJ, Konstam MA et al. Impact of chronic kidney disease and anemia on hospitalization expense in patients with left ventricular dysfunction. Am J Cardiol 2003; 92:1300-1305
(check this in PDF content)
23
Selby JV, Ray GT, Zhang D et al. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care 1997; 20:1396-1402 Поступила в редакцию 27.04.2010 г. Принята в печать 02.06.2010 г.
(check this in PDF content)